Sign In
NewsRadar

Affectis Pharmaceuticals AG

Affectis is a biopharmaceutical company focusing on the development and commercialisation of novel drugs against depression, bipolar affective disorders, and anxiety.

• Show past press releases
• Edit this company

Elevator Pitch
Affectis identified and validated several innovative target genes that play an important role in depression and anxiety. These target genes are directly drugable and can lead to the discovery of entirely new classes of antidepressants that will address the increasing need for more comprehensive and faster-acting treatments with fewer side-effects.

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Fraunhoferstrasse 13
Martinsried 82152
Germany
+49 (0)89 – 89 328 11 – 100
+49 (0)89 – 89 328 11 – 111
http://www.affectis.com
Alex Martin
+49 (0)89 – 89 328 11 – 100

Company Facts
Founded:
Founders:Florian Holsboer, Herbert Stadler
CEO:Alex Martin
CTO or technical lead:Michael Bös
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

  • Florian Holsboer, Director, Max-Planck-Institue of Psychiatry
  • Joachim Rothe, Partner, Life Sciences Partners (LSP)
  • Christof Antz, Managing Director, EMBL Ventures

    Key Customers

    Key Business Partners

    Key Competitors

    Capital Raised
    DateSizeInvestors
    To view this information you must be signed in and subscribed to the online dataservice, sign in here.

    To read more about the Online data service click here

    Public Offerings
    DateTypeExchange
    No public offerings


  • Data


    26,008
    Tech investments
    From our Online Data Service
    16,823
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Aug 19€7.0MAgriculture related
    Aug 19€9.0MInternet commerce
    Aug 19€10.0ME-Commerce
    Aug 19€63.0MBusiness applications
    Aug 16€16.0ME-Commerce
    Aug 16€6.0MBusiness applications
    Aug 15€20.0MGames

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    May 28
    Identiq
    identiq raises $5m seed, launches privacy-first identity validation...

    Apr 29
    Nethone
    nethone raised over $1 million from innovation nest

    Oct 1
    The Link App
    the link app launches version 2.0

    Mar 29
    Addex Therapeutics
    addex sucessfully raises chf40 million in capital increase

    Jan 2
    Urban Jungle
    urban jungle raises £1m in seed funding to build tech-enabled home ...





    About usContact usLegal Information
    Copyright © 1999-2019
    Emerging Technology Research Europe Inc. All rights reserved.